TGFA and non-small cell lung carcinoma: As in NSCLC, a trend to increased TGF-α levels was observed in HNC (Supplementary Figure 2) and nine out of 34 patients were positive (23.5% sensitivity with 97.7% specificity) when setting a cutoff point of 14.4 pg ml−1 (mean+2s.d.